Botulinum Toxin Injection to Prevent VT Storm

• Status: Unknown status
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in left ventricle for preventing episodes of VT Storm.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Meshalkin Research Institute of Pathology of Circulation
• Treatments: Botulinum Toxins

Criteria

Inclusion Criteria:

• 3 or more episodes of ventricular tachycardia within 24 hours

Exclusion Criteria:

• Failure to provide informed consent.

• Non-cardiac illness with a life expectancy of less than 3 year

• Non-cardiac illness imposing substantial operative mortality

• Current participation in another clinical trial in which a patient is taking an investigational drug or receiving an investigational medical device